In order to counter the impending shortage of skilled professionals in the aging societies of our time in many western countries such as Germany, solutions for business and society are urgently needed. Here, artificial intelligence (AI) can play an important role in mitigating the problem with the help of diverse applications. At the same time, it is important to consider both the needs of the respective employee1 and the company to ensure that the use of AI has a positive impact on the organization and finds social acceptance. In this article, we describe the newly developed OSQE model (Optimize, Secure, Qualify, Expand), which for the first time outlines an AI cycle against the shortage of skilled professionals in a holistic approach that focuses equally on people and companies. This can serve organizations as a guide for strategy development, decision-making for and implementation of AI-supported measures in an entire cycle of an employee's affiliation with a company. The model takes three driving forces into account: companies, professionals, and AI applications. In the model, the measures to be implemented are prioritized with ascending numbering based on what would be most urgent for a company to implement. All measures relate to areas of action that place people at the center and can be assigned to the classic cycle of belonging of an employee in the company. In this regard, the opportunities that AI offers to professionals and companies are highlighted.

The building sector has a big potential to reduce the material resource demand needed for building construction and therefore, greenhouse gas (GHG) emissions. Digitalisation can help to make use of this potential and improve sustainability throughout the entire building’s life cycle. One way to address this potential is through the integration of Life-Cycle Assessment (LCA) into the building process by employing Building Information Modelling (BIM). BIM can reduce the effort needed to carry out an LCA and therefore facilitate the integration into the building process. A review of current industry practice and scientific literature shows two main approaches to address BIM-LCA integration. Either the LCA is performed in a simplified way at the beginning of the building process, or it is done at the very end when all the needed information is available, but it is too late for decision-making. One reason for this is the lack of methods, workflows and tools to implement BIM-LCA integration over the entire building process. Therefore, the main objective of this study is to develop an integrated BIM-LCA workflow implemented into a method for the whole building process using an existing structure for cost estimation. A tool is created and used in a case study in Switzerland to test the developed approach. The results of this study show that LCA can be performed continuously in each building phase over the entire building process using existing BIM modelling techniques. The main benefit of this approach is that the re-work caused by the need for re-entering data and the usage of many different software tools that characterise most of the current LCA practices is minimised. Furthermore, decision-making, both at the element and building levels, is supported.

This research aimed to determine the most viable locations for establishing solar energy facilities in Yemen through the utilization of the Analytical Hierarchy Process (AHP), Best-Worst Method (BWM), and Geographic Information System (GIS). A total of twelve key criteria were meticulously selected and evaluated based on their impact on the appropriateness of sites for solar power plants. These criteria were amalgamated using a weighted overlay tool, resulting in a map that classified regions as either optimal, highly suitable, or suitable. The findings of the study indicated that the eastern, southern, and northern parts of Yemen are prime candidates for solar energy installations due to their moderate climate and flat topography. On the other hand, the western regions were deemed less favorable. The breakdown of site classifications revealed that 38% of areas were optimal, 61% were highly suitable, and only 1% were considered suitable, based on the assigned weights from the AHP and BWM methodologies. Moreover, a sensitivity analysis was carried out to evaluate the impact of adjusting the weights of Global Horizontal Irradiance (GHI) and slope on site classifications. A minor increase in the weights of GHI (from 30% to 31%) and slope (from 10% to 11%) resulted in a significant alteration in the suitability categories, highlighting the importance of weight adjustments in multi-criteria decision-making processes. In conclusion, the study emphasizes the effectiveness of AHP, BWM, and GIS in assessing site suitability for solar energy facilities, as well as the significance of sensitivity analyses. These approaches provide valuable insights for decision-makers, aiding in strategic planning and fostering sustainable energy development in Yemen.

This paper explores the challenges faced by blue-collared international migrants in adapting to new and unfamiliar climates while pursuing job opportunities, with a focus on poverty alleviation. Drawing on existing research and empirical evidence, the study investigates the trials encountered by these migrants as they navigate climate shocks and assesses the potential impacts on poverty reduction efforts. The findings underscore the significant difficulties blue-collared migrants experience when confronted with abrupt changes in climate conditions, adversely affecting their physical and mental well-being, as well as their employment prospects. The process of adjustment involves not only acclimating to new climate patterns but also navigating cultural nuances and social dynamics, exacerbating stress and feelings of isolation. Consequently, these challenges can perpetuate poverty by disrupting employment stability and limiting opportunities for career advancement. To address these issues, the paper proposes comprehensive support measures, including targeted pre-departure training programs, access to retraining opportunities, and assistance in securing sustainable livelihoods. By prioritizing climate resilience and empowering blue-collared migrants to adapt effectively to new climates, it becomes possible to enhance their livelihood prospects, reduce poverty levels, and foster sustainable development. The paper concludes by highlighting the significance of integrating climate adaptation strategies with poverty alleviation efforts to create a more inclusive and resilient future for blue-collared migrants in their pursuit of sustainable livelihoods.

The influence and importance of research and development (R&D) for business sustainability have gained increasing interests, especially in the high-tech sector. However, the efforts of R&D might cause complex and mixed impacts on the financial results considering the associated expenses. Thus, this study aims to examine how R&D efforts may influence business to improve its financial performance considering the dual objectives: the gross and the net profitability. This research integrated a rough-set-based soft computing technique and multiple criteria decision-making (MCDM) methods to explore this complex and yet valuable issue. A group of public listed companies from Taiwan, all in the semiconductor sector, was analyzed as a case study. Initially, more than 30 variables were considered, and the adopted soft computing technique retrieved 14 core attributes—for the dual profitability objectives—to form the evaluation model. The importance of R&D for pursuing superior financial prospects is confirmed, and the empirical case demonstrates how to guide an individual company to plan for improvements to achieve its long-term sustainability by this hybrid approach.

Abstract:The digital landscape is rapidly reshaping under the influence of AI-powered cloud-based e-commerce platforms (PCEPs). These platforms leverage the transformative power of AI to personalize customer experiences, optimize pricing strategies, enhance security, and streamline operations, offering businesses a significant competitive edge. However, challenges surrounding data privacy, algorithmic bias, and potential job displacement raise crucial ethical questions regarding widespread AI adoption in e-commerce.This study delves into the untapped potential and ethical considerations of PCEPs, distinguishing itself by proposing practical strategies for responsible development and ethical implementation.Objectives: Investigate the transformative potential of PCEPs: Personalized product recommendations:Analyze effectiveness and potential bias. Dynamic pricing strategies:Explore impact on consumer fairness and market stability. Enhanced fraud detection:Evaluate accuracy and privacy implications. Optimized supply chain management:Assess efficiency gains and job displacement risks. Critically analyze the ethical considerations of AI in e-commerce: Data privacy:Assess current practices and develop mitigation strategies. Algorithmic bias:Identify potential sources and propose solutions for fairer decision-making. Job displacement:Evaluate impacts and propose reskilling initiatives. Propose comprehensive and practical strategies for responsible PCEP development and implementation: Transparency:Enhance user awareness and control over data usage. Fairness:Design AI systems to mitigate bias and uphold consumer rights. Accountability:Establish clear guidelines and oversight mechanisms for ethical AI development.Conclusion: While PCEPs offer a plethora of transformative benefits, their ethical implementation is paramount. By adhering to principles of transparency, fairness, and accountability, businesses can unlock the full potential of PCEPs while minimizing potential risks and shaping the future of online commerce in a sustainable and equitable manner

As a result of decades of austerity, the economies of the Eurozone are experiencing under-investment and crumbling infrastructures in an era of extremely severe emergencies as the cli-mate change and aggressive global competition. The private savings glut of the rich and the strict fiscal rules suggest a crowding-in approach in partnership with big finance in a new age of in-fra-structures. If governments mint public infrastructures into investable assets, they can gen-erate steady returns for investors and asset managers who look after pensions and insurances schemes and unlock trillions now devoted to welfare state. For the big finance to accept to be partner, however, governments must take the task of de-risking returns. Innovation technology and macro-financial literacy can synergically act to enhance this new de-risking role to address in a financially sustainable way the intense phenomena of Natural Hazards (NHs) that can severely compromise economic growth. This is precisely the aim of our Public-Private Partnership (PPP) among the Department of Economics, Management and Institutions of the University of Naples and a Knowledge Transfert Management, the Department of Engineering and the Aca-demic Spin-Off “STRAIN”, of the University of Campania. Our PPP has been contributing to the eval-uation and mitigation of NHs such as floods, landslides and earthquakes since 2012. The ex-tremely advanced results of this multi-stakeholder partnership ensure a better knowledge of NHs which, as evidenced in the paper, is the fundamental input for the desired Public-Private In-surance Programmes (PIPPs).

This paper offers a comprehensive examination of the process involved in developing and automating supervised end-to-end machine learning workflows for forecasting and classification purposes. It offers a complete overview of the components (i.e. feature engineering, model selection, etc), principles (i.e. bias-variance decomposition, model complexity, overfitting, model sensitivity to feature assumptions and scaling, output interpretability, etc), models (i.e. neural networks, regression models, etc), methods (i.e. Cross-Validation, data augmentation, etc), metrics (i.e. Mean Squared Error, F1-score, etc) and tools that rule most supervised learning applications with numerical and categorical data, as well as their integration, automation, and deployment. The end goal and contribution of this paper is the education and guidance of the non-AI expert academic community over complete and rigorous machine learning pipelines and data science practices, from problem scoping to design and state-of-the-art automation tools, including basic principles and reasoning in the choice of methods. The paper delves into the critical stages of supervised machine learning workflow development, many of which are often omitted by researchers due to brevity, and covers foundational concepts essential for understanding and optimizing a functional machine learning workflow, thereby offering a holistic view of task-specific application development for applied researchers who are not AI experts.

The goods and services produced by forest vegetation ecosystem are the driving force for the rapid, high-quality and sustainable development of human society. In history, with the increase of population and economic development, there is an increasing demand for the quantity and variety of forest vegetation ecosystem products and services in a country or a region. To meet the demands, most of the original forest has become farmland, plantation and grass and crops land. As a result, the plant water relationship changed from equilibrium to non-equilibrium, which easily led to soil drought, soil degradation and vegetation decline in dry years or waste of soil water in rainy years in most of water-limited regions. In order to solve the question and realize the sustainable utilization of soil water resources and the high-quality sustainable development of forest, it is necessary to apply the limit theory of plant utilization of soil water resources and the vegetation carrying capacity theory in the critical period of plant-water relationship regulation to adjust the relationship between plant growth and soil moisture to obtain the maximum yield and benefit and realize high-quality and sustainable development.

In August 4 2011, United Nations Environmental Program (UNEP) submitted an unprecedented, scientific, groundbreaking Environmental Assessment Report (EAR) of Ogoniland, to the Nigerian government. This was the outcome of a 14–month intensive evaluation of the extent of pollution. It was intended that UNEP’s recommendations would be implemented to restore the devastated environment, on the one hand, and on the other, counteract the numerous environmental health issues that have for decades, plagued Ogoniland. However, five years post EAR, and, despite the seriousness of the situation, no significant resolution has occurred, both on the part of the government, and on the part of Shell Petroleum Development Company (SPDC) or Shell. To date, millions of Niger Delta residents, particularly those living in the oil-bearing communities, continue to suffer severe consequences. Although, the assessment was conducted in Ogoniland, other communities in the Niger Delta are also affected. This article explores prevailing issues, using Ogoniland (a microcosm of the Niger Delta) as an example. A multidisciplinary approach for sustainable mitigation of environmental health risks in the Niger Delta is paramount, and Environmental Management tools offer valuable strategies. Adopting UNEP’s recommendations for addressing environmental health problems requires implementing the Environmental Management/Environmental Management System (EM/EMS) model.

Fossils constitute the principal repository of data that allow for independent tests of hypotheses of biological evolution derived from observations of the extant biota. Traditionally, transformational series of structure, consisting of sequences of fossils of the same lineage through time, have been employed to reconstruct and interpret morphological evolution. More recently, a move toward an updated paradigm was fueled by the deliberate integration of developmental thinking in the inclusion of fossils in reconstruction of morphological evolution. The vehicle for this is provided by structural fingerprints – recognizable morphological and anatomical structures generated by (and reflective of) the deployment of specific genes and regulatory pathways during development. Furthermore, because the regulation of plant development is both modular and hierarchical in nature, combining structural fingerprints recognized in the fossil record with our understanding of the developmental regulation of those structures produces a powerful tool for understanding plant evolution. This is particularly true when the systematic distribution of specific developmental regulatory mechanisms and modules is viewed within an evolutionary (paleo-evo-devo) framework. Here, we discuss several advances in understanding the processes and patterns of evolution, achieved by tracking structural fingerprints with their underlying regulatory modules across lineages, living and fossil: the role of polar auxin regulation in the cellular patterning of secondary xylem and the parallel evolution of arborescence in lycophytes and seed plants; the morphology and life history of early polysporangiophytes and tracheophytes; the role of modularity in the parallel evolution of leaves in euphyllophytes; leaf meristematic activity and the parallel evolution of venation patterns among euphyllophytes; mosaic deployment of regulatory modules and the diverse modes of secondary growth of euphyllophytes; modularity and hierarchy in developmental regulation and the evolution of equisetophyte reproductive morphology. More generally, inclusion of plant fossils in the evo-devo paradigm has informed discussions on the evolution of growth patterns and growth responses, sporophyte body plans and their homology, sequences of character evolution, and the evolution of reproductive systems.

BackgroundThe present review summarizes the state-of-the-art of in silico methods and techniques that are the most useful in drug discovery, their relationship with data science, as well as the successful application of data science, machine learning (ML) and artificial intelligence (AI) applications. A meta-analysis of the various technologies available is furthermore proposed as a guideline for the non-expert, reader relative to the several subject areas is also discussed in this article. The scope of this meta-analysis is to rank the enlisted technologies by their field of applications and to depict the latter according to knowledge accessibility, from students to experts.Method The search strategy utilized for this review first produced a general collection of 900 papers without duplications, which were subsequently streamlined and divided into two independent collections: the top 300 most-cited papers of all time (since 2000) and the papers with the highest interest for a systematic review analysis (high-impact exciting papers). Results In Part 1, we discuss the most cited and quality 97 articles in these top 300 papers most relevant to the field of in silico drug discovery. The different disciplines are listed according to their industrial and economic incurred to society, independently from the “metric” results of how many new drug approvals (NDAs) each discipline has generated to date.ConclusionBig data, the ensemble of known items stored in publicly available databases, has improved our understanding of the many fates of a potential drug candidate during its development and even after its commercialization. Moreover, the combination of new screening techniques and “omics” with old drugs has led to a new paradigm in which the unknown knowledge of any biological molecule and its cellular structure, now plays an important role as a target for a series of yet-to-be-developed drugs: the chemical space. Furthermore, leveraging big data, data science, ML, and AI can revolutionize drug discovery by swiftly analyzing massive datasets, predicting efficacy and safety profiles, streamlining development, cutting costs, and boosting success rates for new drugs. AI also speeds up the search for promising drug candidates, advancing innovative therapies.

As a pioneering transdisciplinary field, innovationology transcends the traditional boundaries of academic disciplines and development practices to address persistent global challenges. This article provides a comprehensive exploration of innovationology, delving deep into its philosophical foundations, ontological commitments, and ethical imperatives. By unpacking the core tenets of this innovative approach, the paper positions it as a robust and holistic science capable of catalyzing transformative innovation and sustainable development worldwide. Innovationology represents a paradigm shift that moves beyond conventional innovation and development theories, embracing a systems-oriented, community-centric, and decolonial praxis. Drawing on a synthesis of theoretical perspectives and empirical insights, the article examines innovationology's ontological commitment to marginalized communities as active agents of change, its epistemological grounding in pluralistic knowledge systems, and its ethical imperatives of social justice, environmental sustainability, and inclusive innovation. This in-depth analysis strengthens the conceptual and theoretical foundations of innovationology, providing critical guidance for its practical implementation and continued refinement as a cutting-edge transdisciplinary science for global transformation.

Tandem mass spectrometry (TMS) has emerged as a critical analytical tool in pharmaceutical sciences, playing a pivotal role in ensuring the rational use of medications. This article explores the applications of TMS across various stages of drug development, quality assurance, and patient care, highlighting its precision and reliability in advancing therapeutic efficacy. TMS facilitates the accurate identification and quantification of drug compounds, ensuring that pharmaceutical products meet high standards of purity and potency. By detecting even trace levels of impurities or contaminants, TMS strengthens the quality control processes critical to patient safety. In the realm of pharmacokinetics and pharmacodynamics, TMS enables detailed monitoring of drug absorption, distribution, metabolism, and excretion (ADME), allowing for a better understanding of drug behavior in the human body. It is also instrumental in therapeutic drug monitoring (TDM), ensuring that medication levels remain within therapeutic windows, thus optimizing dosing regimens and minimizing adverse effects. Additionally, TMS supports personalized medicine approaches by assessing drug interactions and tailoring treatments to individual patients. Through its application in drug discovery, development, and therapeutic monitoring, TMS serves as an indispensable tool for fostering rational medication use, contributing to more effective, safe, and personalized pharmaceutical care.

In an era of rapid technological advancements, complex global challenges, and intense market competition, the ability to generate and scale innovative solutions has become a critical imperative for organizations, policymakers, and societies worldwide. However, the existing academic landscape has lacked a cohesive, multidisciplinary framework for comprehensively understanding the multifaceted nature of innovation. Innovationology, a newly established scientific discipline, aims to address this gap by providing a unifying, transdisciplinary approach to the study and practice of transformative innovation. This comprehensive article introduces Innovationology as a cutting-edge science that integrates insights from diverse fields, including management, psychology, sociology, economics, and technology studies. Innovationology posits that innovation is a multilayered, context-dependent phenomenon, shaped by the intricate interplay of individual, team, organizational, and ecosystem-level factors. By synthesizing the latest theoretical advancements and empirical evidence, this article presents a holistic model of Innovationology that illuminates the key determinants of radical, game-changing innovations capable of disrupting existing industries and creating new market spaces. The article delves deep into the individual cognitive, behavioral, and motivational drivers of innovativeness, the team dynamics and organizational structures that foster collaborative innovation, and the ecosystem-level characteristics that catalyze the emergence and scaling of transformative innovations. Importantly, the article explores the crucial role of contextual factors, such as socio-cultural norms, institutional support, and resource availability, in shaping innovation outcomes. This article also establishes the epistemological foundations of Innovationology, grounding it in a transdisciplinary, holistic, and pragmatic approach to knowledge generation. Innovationology embraces a pluralistic epistemology that acknowledges the complexity and context-dependence of innovation, drawing on diverse methodological approaches to capture the multifaceted nature of this phenomenon. Furthermore, the article outlines the object of Innovationology, which is to provide a comprehensive, evidence-based understanding of the drivers, processes, and outcomes of transformative innovation. Innovationology seeks to elucidate the multilevel determinants of innovation, the dynamic interplay between various factors, and the contextual influences that shape innovation trajectories. By establishing a unifying, transdisciplinary framework, Innovationology aims to bridge the gap between innovation theory and practice, empowering a wide range of stakeholders to unlock the transformative potential of innovation. Importantly, this article outlines the practical applications of Innovationology, providing comprehensive strategies and evidence-based interventions for cultivating innovative mindsets, designing innovation-conducive organizational systems, and navigating the challenges of innovative ecosystems. The implications of Innovationology for entrepreneurs, corporate leaders, policymakers, and innovation scholars are discussed in detail. By establishing Innovationology as a distinct, authoritative scientific discipline, this article sets the foundation for a more holistic, context-sensitive understanding of innovation and its multifaceted drivers. The insights generated by this new science can empower global organizations, institutions, and policymakers to address the complex, interconnected challenges of the 21st century through the strategic deployment of transformative innovations.

The regulatory approvals of tumor agnostic therapies have led to reevaluation of the drug development process. Conventional models of drug development are histology-based. On the other hand, tumor agnostic drug development of a new drug (or combination) focuses on targeting a common genomic biomarker in multiple cancers, regardless of histology. Basket-like clinical trials with multiple cohorts allow clinicians to evaluate pan-cancer efficacy and toxicity. There are currently 8 tumor agnostic approvals granted by the Food and Drug Administration (FDA). This includes two immune checkpoint inhibitors, and 5 targeted therapy agents. Pembrolizumab is an anti-PD-1 antibody that was the first FDA approved tumor agnostic treatment for unresectable or metastatic microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) solid tumors in 2017. It was later approved for tumor mutational burden-high (TMB-H) solid tumors, although the TMB cut-off used is still debated. Subsequently, in 2021, another anti-PD-1 antibody, Dostarlimab was also approved for dMMR solid tumors in the refractory setting. Patients with fusion-positive cancers are typically difficult to treat due to their rare prevalence and distribution. Gene rearrangements or fusions are present in a variety of tumors. neurotrophic tyrosine kinase (NTRK) fusions are present in a range of pediatric and adult solid tumors in varying frequency. Larotrectinib and entrectinib were approved for neurotrophic tyrosine kinase (NTRK) fusion-positive cancers. Similarly, selpercatinib was approved for Rearranged During Transfection (RET) fusion-positive solid tumors. FDA approved the first combination therapy of dabrafenib, a B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) inhibitor, plus trametinib, a mitogen-activated protein kinase (MEK) inhibitor for patients 6 months or older with unresectable or metastatic tumors (except colorectal cancer) carrying BRAFV600E mutation. The most recent FDA tumor agnostic approval is of fam-trastuzumab deruxtecan-nxki (T-Dxd) for HER2-positive solid tumors. It is important to identify and expeditiously develop drugs that have the potential to provide clinical benefit across tumor types.

Two-Dimensional Nuclear Magnetic Resonance (2D NMR) spectroscopy has become a cornerstone in pharmaceutical research, offering enhanced structural elucidation capabilities for complex molecules. This technique overcomes the limitations of one-dimensional (1D) NMR by providing detailed insights into molecular interactions through the use of advanced spectroscopic methods like COSY, HSQC, and HMBC. In pharmaceutical applications, 2D NMR plays a crucial role in drug characterization, quality control, formulation development, and the structural analysis of natural products. Recent technological advancements such as high-field spectrometers and cryogenic probes have further improved the sensitivity and resolution of 2D NMR, making it indispensable for ensuring drug quality and intellectual property protection. This article delves into the principles and applications of 2D NMR in the pharmaceutical industry, highlighting its critical contributions to drug discovery, development, and quality assurance. Additionally, it addresses the future prospects of 2D NMR in areas like metabolomics, structural biology, and the development of new analytical tools. Despite its numerous advantages, 2D NMR presents challenges such as high operational costs, complexity in data analysis, and sensitivity issues when dealing with low-concentration samples. The article concludes by discussing the ongoing advancements in 2D NMR technology and its evolving role in pharmaceutical innovation.

The article titled "Immunoglobulins and Its Applications" provides a comprehensive overview of the structure, function, and therapeutic significance of immunoglobulins, also known as antibodies. These vital proteins, produced by plasma cells in response to immunogens, are essential components of the immune system, playing a critical role in recognizing and neutralizing pathogens such as bacteria and viruses. The article elaborates on the five primary classes of immunoglobulins (IgA, IgD, IgE, IgG, and IgM), each distinguished by its unique structural and functional properties. It discusses the molecular composition of immunoglobulins, highlighting the significance of their variable and constant regions in antigen binding. The paper also explores the diverse immune functions mediated by these proteins, including precipitation, agglutination, and neutralization of antigens. Additionally, the article emphasizes the therapeutic applications of immunoglobulins, particularly in treating immune deficiencies and other diseases. Advances in monoclonal antibody technology have significantly expanded the utility of immunoglobulins in both research and medicine, leading to the development of innovative therapeutic approaches such as humanized monoclonal antibodies and bifunctional antibodies. This comprehensive analysis underscores the critical role of immunoglobulins in both natural immunity and therapeutic interventions.